Skip to main content

Advertisement

SpringerLink
Log in

Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema

  • Laboratory Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the pathogenesis of diffuse diabetic maculae edema (DME).

Methods

Internal limiting membrane (ILM) specimens were surgically peeled from 16 eyes of 15 patients with diffuse DME (diabetic retinopathy (DR) group) and from 12 eyes of 12 patients without diabetes (non-DR group). The specimens were then examined by light microscopy (LM), transmission electron microscopy (TEM), and immunohistochemistry.

Results

Examination by LM revealed numerous cells on the inner surface of the ILM specimens in the DR-group, among which five different cell types (glial cell, fibroblast-like cell, macrophages, neutrophils, and lymphocytes) were confirmed. Examination by TEM revealed that the thickness of the peeled ILMs in the DR group was significantly greater, and four types of cellular element (glial, fibroblast-like, macrophages, and lymphocytes) were confirmed on the surface of the vitreous side of the specimens. The existence of glial cells and macrophages was confirmed by immunohistochemistry.

Conclusions

In diffuse DME, the ILM is thickened and a variety of cellular elements, especially numerous kinds of inflammatory cell, adhere to the inner surface of the ILM. To attenuate diffuse DME, vitrectomy combined with ILM peeling to remove the inflammatory cells and the physical barrier might be effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–9.

    PubMed  CAS  Google Scholar 

  2. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258–60.

    PubMed  CAS  Google Scholar 

  3. Terasaki H, Kojima T, Niwa H, Piao C, Ueno S, Kondo M, et al. Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci. 2003;44:4465–72.

    Article  PubMed  Google Scholar 

  4. Ikeda T, Sato K, Katano T, Hayashi Y. Improve visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina. 2000;20:220–2.

    Article  PubMed  CAS  Google Scholar 

  5. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132:369–77.

    Article  PubMed  CAS  Google Scholar 

  6. Patel JI, Hykin PG, Schadt M, Luong VY, Fitzke F, Gregor Z. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina. 2006;26:5–13.

    Article  PubMed  Google Scholar 

  7. Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina. 2008;28:410–9.

    Article  PubMed  Google Scholar 

  8. Kim YM, Chung EJ, Byeon SH, Lee S, Kwon OH, Koh HJ. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Ophthalmologica. 2009;223:17–23.

    Article  PubMed  CAS  Google Scholar 

  9. Recchia FM, Ruby A, Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447–54.

    Article  PubMed  Google Scholar 

  10. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243:20–5.

    Article  PubMed  Google Scholar 

  11. Kumar A, Sinha S, Azad R, Sharama YR, Vohra R. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:360–8.

    Article  PubMed  Google Scholar 

  12. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Visual outcome of patient with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2004;242:273–8.

    Article  PubMed  Google Scholar 

  13. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina. 2000;20:126–33.

    Article  PubMed  CAS  Google Scholar 

  14. Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina. 2005;25:311–6.

    Article  PubMed  Google Scholar 

  15. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996;44:1469–79.

    Article  PubMed  CAS  Google Scholar 

  16. Kohno T, Sorgente N, Goodnight R, Ryan S. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 1987;28:515–21.

    PubMed  CAS  Google Scholar 

  17. Heij EC, Dieudonne SC, Mooy CM, Diederen R, Liem A, Suylen R, et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol. 2005;140:1123–5.

    Article  PubMed  Google Scholar 

  18. Fine BS. Limiting membranes of the sensory retina and pigment epithelium. An electron microscopic study. Arch Ophthalmol. 1961;66:847–60.

    Article  PubMed  CAS  Google Scholar 

  19. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7.

    Article  PubMed  CAS  Google Scholar 

  20. Suzuki Y, Nakazawa M, Suzuki K, Yamazaki H, Miyagawa Y. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol. 2011;55:256–63.

    Article  PubMed  CAS  Google Scholar 

  21. Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T, et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci. 2001;42:229–34.

    PubMed  CAS  Google Scholar 

  22. Haritoglou C, Gandorfer A, Gass CA, Shaumberger M, Ulbig MW, Kampik A. The effect of indocyanine green on functional outcome of macular pucker surgery. Am J Ophthalmol. 2003;135:328–37.

    Article  PubMed  CAS  Google Scholar 

  23. Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol. 2002;134:661–6.

    Article  PubMed  Google Scholar 

  24. Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol. 2004;137:609–14.

    PubMed  Google Scholar 

  25. Gandorfer A, Haritoglou C, Gass CA, Ulbig W, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001;132:431–3.

    Article  PubMed  CAS  Google Scholar 

  26. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86:363–5.

    Article  PubMed  CAS  Google Scholar 

  27. Kalvoda J, Duskova J, Kubena A, Povysul C, Kalvodova B. Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247:1307–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima, Tokyo, 177-8521, Japan

    Kaoru Tamura & Toshiyuki Yokoyama

  2. Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan

    Nobuyuki Ebihara & Akira Murakami

Authors
  1. Kaoru Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuyuki Ebihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akira Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaoru Tamura.

About this article

Cite this article

Tamura, K., Yokoyama, T., Ebihara, N. et al. Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema. Jpn J Ophthalmol 56, 280–287 (2012). https://doi.org/10.1007/s10384-012-0130-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-012-0130-y

Keywords

Search

Navigation